These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 23781712)

  • 1. [Copper intoxication decreases lifespan and induces neurologic alterations in Drosophila melanogaster].
    Arcaya JL; Tejeda CM; Salazar U; Silva EJ; Urdaneta K; Varela K
    Invest Clin; 2013 Mar; 54(1):47-57. PubMed ID: 23781712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute and chronic metal exposure impairs locomotion activity in Drosophila melanogaster: a model to study Parkinsonism.
    Bonilla-Ramirez L; Jimenez-Del-Rio M; Velez-Pardo C
    Biometals; 2011 Dec; 24(6):1045-57. PubMed ID: 21594680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dopaminergic system activation on feeding behavior and growth performance of the sea bass (Dicentrarchus labrax): a self-feeding approach.
    Leal E; Fernández-Durán B; Agulleiro MJ; Conde-Siera M; Míguez JM; Cerdá-Reverter JM
    Horm Behav; 2013 Jun; 64(1):113-21. PubMed ID: 23747830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the motor response to dopaminergic drugs in a parkinsonian model of combined dopaminergic and noradrenergic degeneration.
    Pérez V; Sosti V; Rubio A; Barbanoj M; Rodríguez-Alvarez J; Kulisevsky J
    Eur J Pharmacol; 2007 Dec; 576(1-3):83-90. PubMed ID: 17888901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MK-801 alters the effects of priming with L-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons.
    Van De Witte SV; Groenewegen HJ; Voorn P
    Synapse; 2002 Jan; 43(1):1-11. PubMed ID: 11746728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy.
    Chartoff EH; Szczypka MS; Palmiter RD; Dorsa DM
    Brain Res; 2004 Oct; 1022(1-2):71-80. PubMed ID: 15353215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dopamine D4 receptor-selective antagonists on motor hyperactivity in rats with neonatal 6-hydroxydopamine lesions.
    Zhang K; Davids E; Tarazi FI; Baldessarini RJ
    Psychopharmacology (Berl); 2002 Apr; 161(1):100-6. PubMed ID: 11967637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: II. Actions in rodent, primate, and cellular models of antiparkinsonian activity in comparison to ropinirole.
    Millan MJ; Di Cara B; Hill M; Jackson M; Joyce JN; Brotchie J; McGuire S; Crossman A; Smith L; Jenner P; Gobert A; Peglion JL; Brocco M
    J Pharmacol Exp Ther; 2004 Jun; 309(3):921-35. PubMed ID: 14978195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-DOPA-induced increase in TH-immunoreactive striatal neurons in parkinsonian mice: insights into regulation and function.
    Espadas I; Darmopil S; Vergaño-Vera E; Ortiz O; Oliva I; Vicario-Abejón C; Martín ED; Moratalla R
    Neurobiol Dis; 2012 Dec; 48(3):271-81. PubMed ID: 22820144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minocycline, but not ascorbic acid, increases motor activity and extends the life span of Drosophila melanogaster.
    Mora M; Medina-Leendertz SJ; Bonilla E; Terán RE; Paz MC; Arcaya JL
    Invest Clin; 2013 Jun; 54(2):161-70. PubMed ID: 23947005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A synaptic mechanism underlying the behavioral abnormalities induced by manganese intoxication.
    Calabresi P; Ammassari-Teule M; Gubellini P; Sancesario G; Morello M; Centonze D; Marfia GA; Saulle E; Passino E; Picconi B; Bernardi G
    Neurobiol Dis; 2001 Jun; 8(3):419-32. PubMed ID: 11442351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impairment of dopaminergic system function after chronic treatment with corticotropin-releasing factor.
    Izzo E; Sanna PP; Koob GF
    Pharmacol Biochem Behav; 2005 Aug; 81(4):701-8. PubMed ID: 16005056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian-dependent effect of melatonin on dopaminergic D2 antagonist-induced hypokinesia and agonist-induced stereotypies in rats.
    Sumaya IC; Byers DM; Irwin LN; Del Val S; Moss DE
    Pharmacol Biochem Behav; 2004 Aug; 78(4):727-33. PubMed ID: 15301928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The partial dopamine agonist pardoprunox (SLV308) administered in combination with l-dopa improves efficacy and decreases dyskinesia in MPTP treated common marmosets.
    Tayarani-Binazir K; Jackson MJ; Rose S; McCreary AC; Jenner P
    Exp Neurol; 2010 Dec; 226(2):320-7. PubMed ID: 20843474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Locomotor response to L-DOPA in reserpine-treated rats following central inhibition of aromatic L-amino acid decarboxylase: further evidence for non-dopaminergic actions of L-DOPA and its metabolites.
    Alachkar A; Brotchie JM; Jones OT
    Neurosci Res; 2010 Sep; 68(1):44-50. PubMed ID: 20542064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation.
    Darmopil S; Martín AB; De Diego IR; Ares S; Moratalla R
    Biol Psychiatry; 2009 Sep; 66(6):603-13. PubMed ID: 19520364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of medial prefrontal cortex dopamine in age differences in response to amphetamine in rats: locomotor activity after intra-mPFC injections of dopaminergic ligands.
    Mathews IZ; McCormick CM
    Dev Neurobiol; 2012 Nov; 72(11):1415-21. PubMed ID: 22081646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine receptor agonists reverse behavioral abnormalities of alpha-synuclein transgenic mouse, a new model of Parkinson's disease.
    Wakamatsu M; Iwata S; Funakoshi T; Yoshimoto M
    J Neurosci Res; 2008 Feb; 86(3):640-6. PubMed ID: 17896793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests.
    Bristow LJ; Collinson N; Cook GP; Curtis N; Freedman SB; Kulagowski JJ; Leeson PD; Patel S; Ragan CI; Ridgill M; Saywell KL; Tricklebank MD
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1256-63. PubMed ID: 9400001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.